Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update

Jun 2, 2026 - 03:25

0 0

Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update

Shares of French biotech Abivax tumbled 32% after it reported fresh data on its lead asset.

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

In my latest attempt to save money, I got an entire season's worth of clothes for free using 'Buy Nothing' groups

In my latest attempt to save money, I got an entire sea...

Jun 21, 2026 0 0

What is GLM-5.2? Another open-source Chinese AI model has Silicon Valley's attention.

What is GLM-5.2? Another open-source Chinese AI model h...

Jun 21, 2026 0 0

She saved $24,000 to launch a craft festival in an old Joann store: 'This is my dream come true'

She saved $24,000 to launch a craft festival in an old ...

Jun 21, 2026 0 0

The AI trade has left the hyperscalers in the dust. What will it take for that to change?

The AI trade has left the hyperscalers in the dust. Wha...

Jun 21, 2026 0 0

I left the Navy SEALs to have more time with my 3 kids. What I learned in the military helped me raise confident kids.

I left the Navy SEALs to have more time with my 3 kids....

Jun 21, 2026 0 0

Drones that Ukraine built to spy and attack are now hauling water, ammo, and medicine to the front

Drones that Ukraine built to spy and attack are now hau...

Jun 21, 2026 0 0